1-3 of 3
Gary Hicks
Close
Sort by
Journal Articles

A 10 Day Schedule of Azacitidine Induces More Complete Cytogenetic Remissions Than the Standard Schedule In Myelodysplasia and Acute Myeloid Leukemia with Myelodysplasia-Related Changes: Results of the E1905 US Leukemia Intergroup Study

Thomas Prebet, M.D., Ph.D., Zhuoxin Sun, PhD, Rhett Ketterling, Gary Hicks, Ph.D., C.L. Beach, PharmD, Peter L. Greenberg, MD, Elisabeth Paietta, PhD, Magdalena Czader, M.D., Ph.D., Janice Gabrilove, M.D., Harry P Erba, DM, PhD, Martin S. Tallman, MD, Steven D. Gore, M.D.
Journal: Blood
Blood (2010) 116 (21): 4013.
https://doi.org/10.1182/blood.V116.21.4013.4013
Published: 2010
Journal Articles

Utility of Interphase FISH To Stratify Patients into Cytogenetic Risk Categories at Diagnosis of AML in an ECOG Clinical Trial (E1900).

Gail H. Vance, Haesook Kim, Gary Hicks, Athena Cherry, Rodney Higgins, Martin S. Tallman, Hugo F. Fernandez, Gordon Dewald
Journal: Blood
Blood (2005) 106 (11): 2377.
https://doi.org/10.1182/blood.V106.11.2377.2377
Published: 2005
Journal Articles

Dual Inhibition of Blood Coagulation Factors Xa and Iia Synergize To Reduce Thrombus Weight and Thrombin Generation in a Rabbit Arteriovenous Shunt Model of Thrombosis.

Thomas B. McClanahan, MA, Sangita M. Baxi, BS, Liguo Chi, PhD, Tawny Dahring, BS, Weston R. Gould, PhD, Ted Johnson, PhD, Gary Hicks, Kathy Welch, BS, Robert J. Leadley, PhD
Journal: Blood
Blood (2005) 106 (11): 1866.
https://doi.org/10.1182/blood.V106.11.1866.1866
Published: 2005